A comprehensive view of Immune System Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Consumer packaged goods (CPG) Market Intelligence Service.
Novartis acquires IFM Therapeutics subsidiary IFM Due for US$90.0M upfront, plus potential milestones totaling US$835.0M; Novartis gets full rights to the STING antagonist program developed in a four-year research collaboration
Published:
March 13, 2024
by Associated Press
|
Sanofi emphasizes immunology education during British Science Week, partners with artists for meningitis awareness ahead of Paris 2024 Olympics; the company advocates for rare diseases with its 'Raras Pero Reales' Initiative,
Published:
March 12, 2024
by Industry Intelligence Inc.
|
Merck faces 185 lawsuits filed in Charlotte, North Carolina, that allege Merck’s Gardasil HPV vaccine could cause autoimmune disorders, premature ovarian failure and cancer; CDC and FDA reaffirm the vaccine's safety and effectiveness
Published:
March 11, 2024
by Charlotte Observer
|
AstraZeneca plans 15 new drug releases in India by 2025 targeting cancer, respiratory and immunology, and rare diseases; new releases are part of its expansion strategy boosted by tiered pricing approach and public-private partnerships
Published:
March 11, 2024
by IIFL Securities (India)
|
FDA approves Fresenius Kabi's Tyenne, a biosimilar tocilizumab drug for inflammatory and immune diseases referencing Actemra tocilizumab in both IV and subcutaneous formulations; this marks the company's third biosimilar approval in the US
Published:
March 08, 2024
by ENP Newswire
|
Ask us about our Consumer packaged goods (CPG) market view